| Aktie | Ticker | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 360.208.609 $ | +76.924.711 $ | +23,3 % | 318.102.880 $ | +74.239.119 $ | +66,8 % | 273.045.105 $ | +46.155.360 $ | +44,7 % | 260.119.590 $ | +3.584.078 $ | +6,5 % | ||
| Erasca, Inc. | ERAS | 56.403.011 $ | +36.294.908 $ | +180,5 % | 20.108.103 $ | +8.324.322 $ | +70,6 % | 11.783.781 $ | +4.918.918 $ | +71,7 % | 6.864.863 $ | -540.540 $ | -7,3 % |
| Entrada Therapeutics, Inc. | TRDA | 51.191.503 $ | +9.491.927 $ | +22,8 % | 41.699.576 $ | +17.012.578 $ | +68,9 % | 24.686.998 $ | -4.265.309 $ | -14,7 % | 28.952.307 $ | -10.899.439 $ | -27,3 % |
| Skye Bioscience, Inc. | SKYE | 5.950.412 $ | -1.308.006 $ | -18,0 % | 7.258.418 $ | -30.790.911 $ | -80,9 % | 38.049.329 $ | -3.387.713 $ | -8,2 % | 41.437.042 $ | +25.675.105 $ | +162,9 % |
| Tyra Biosciences, Inc. | TYRA | 39.422.113 $ | +12.361.869 $ | +45,7 % | 27.060.244 $ | +13.919.465 $ | +105,9 % | 13.140.779 $ | +4.151.697 $ | +46,2 % | 8.989.082 $ | +253.611 $ | +2,9 % |
| Camp4 Therapeutics Corp | CAMP | 25.882.691 $ | -10.094.837 $ | -28,1 % | 35.977.528 $ | +18.370.255 $ | +104,3 % | 17.607.273 $ | +13.361.796 $ | +314,7 % | 4.245.477 $ | -7.466.183 $ | -63,7 % |
| Centessa Pharmaceuticals plc | CNTA | 23.075.135 $ | +8.545.701 $ | +58,8 % | 14.529.434 $ | -1.983.482 $ | -12,0 % | 16.512.916 $ | +5.594.299 $ | +51,2 % | 10.918.617 $ | -1.030.372 $ | -8,6 % |
| Viridian Therapeutics, Inc.\DE | VRDN | 22.922.836 $ | +7.027.116 $ | +44,2 % | 15.895.720 $ | +5.598.122 $ | +54,4 % | 10.297.598 $ | +368.297 $ | +3,7 % | |||
| Pharvaris N.V. | PHVS | 22.532.200 $ | +398.800 $ | +1,8 % | 22.133.400 $ | +2.233.280 $ | +11,2 % | 19.900.120 $ | +5.862.360 $ | +41,8 % | 14.037.760 $ | +1.515.440 $ | +12,1 % |
| MapLight Therapeutics, Inc. | MPLT | 19.313.724 $ | +2.626.781 $ | +15,7 % | 16.686.943 $ | +16.686.943 $ | |||||||
| EyePoint, Inc. | EYPT | 13.534.500 $ | -5.649.000 $ | -29,4 % | 19.183.500 $ | +4.231.500 $ | +28,3 % | 14.952.000 $ | +5.071.500 $ | +51,3 % | 9.880.500 $ | +4.189.500 $ | +73,6 % |
| Tectonic Therapeutic, Inc. | TECX | 18.751.861 $ | +6.096.933 $ | +48,2 % | 12.654.928 $ | +4.626.983 $ | +57,6 % | 8.027.945 $ | -2.138.739 $ | -21,0 % | 10.166.684 $ | +1.105.185 $ | +12,2 % |
| Dianthus Therapeutics, Inc. /DE/ | DNTH | 14.364.836 $ | -3.980.591 $ | -21,7 % | 18.345.427 $ | -297.251 $ | -1,6 % | ||||||
| Enliven Therapeutics, Inc. | ELVN | 11.896.146 $ | -3.916.458 $ | -24,8 % | 15.812.604 $ | +316.715 $ | +2,0 % | 15.495.889 $ | -10.530.458 $ | -40,5 % | |||
| Celldex Therapeutics, Inc. | CLDX | 15.773.404 $ | +2.267.551 $ | +16,8 % | 13.505.853 $ | +641.478 $ | +5,0 % | 12.864.375 $ | +2.744.930 $ | +27,1 % | 10.119.445 $ | +1.093.994 $ | +12,1 % |
| Artiva Biotherapeutics, Inc. | ARTV | 15.155.278 $ | +5.059.604 $ | +50,1 % | 10.095.674 $ | +3.341.692 $ | +49,5 % | 6.753.982 $ | +3.200.493 $ | +90,1 % | 3.553.489 $ | -3.506.423 $ | -49,7 % |
| MoonLake Immunotherapeutics | MLTX | 13.325.174 $ | +2.295.205 $ | +20,8 % | |||||||||
| Surrozen, Inc./DE | SRZN | 11.287.875 $ | +2.530.375 $ | +28,9 % | 8.757.500 $ | +4.763.150 $ | +119,2 % | 3.994.350 $ | +1.222.950 $ | +44,1 % | 2.771.400 $ | -843.200 $ | -23,3 % |
| Vor Biopharma Inc. | VOR | 10.305.991 $ | +5.741.455 $ | +125,8 % | |||||||||
| Zentalis Pharmaceuticals, Inc. | ZNTL | 9.238.116 $ | +3.908.433 $ | +73,3 % | 5.329.683 $ | +4.589.783 $ | +620,3 % | 739.900 $ | +171.500 $ | +30,2 % | 568.400 $ | -210.700 $ | -27,0 % |
| Praxis Precision Medicines, Inc. | PRAX | 9.010.000 $ | +1.861.500 $ | +26,0 % | 7.148.500 $ | +710.600 $ | +11,0 % | ||||||
| Biohaven Ltd. | BHVN | 6.251.703 $ | -2.091.291 $ | -25,1 % | 8.342.994 $ | +1.153.624 $ | +16,0 % | 7.189.370 $ | +431.075 $ | +6,4 % | 6.758.295 $ | -4.756.192 $ | -41,3 % |
| GH Research PLC | GHRS | 8.051.670 $ | +778.824 $ | +10,7 % | 7.272.846 $ | -916.264 $ | -11,2 % | 8.189.110 $ | +1.208.324 $ | +17,3 % | 6.980.786 $ | +664.291 $ | +10,5 % |
| Protara Therapeutics, Inc. | TARA | 7.136.564 $ | -164.374 $ | -2,3 % | 7.300.938 $ | +3.820.938 $ | +109,8 % | 3.480.000 $ | +1.056.000 $ | +43,6 % | 2.424.000 $ | -984.000 $ | -28,9 % |
| ALX ONCOLOGY HOLDINGS INC | ALXO | 6.129.937 $ | +6.129.937 $ | ||||||||||
| Viking Therapeutics, Inc. | VKTX | 5.024.215 $ | +445.544 $ | +9,7 % | |||||||||
| KING LUTHER CAPITAL MANAGEMENT CORP | 4.574.465 $ | +1.416.763 $ | +44,9 % | ||||||||||
| Alector, Inc. | ALEC | 2.947.689 $ | +1.553.512 $ | +111,4 % | 1.394.177 $ | +169.293 $ | +13,8 % | ||||||
| Silence Therapeutics plc | SLN | 2.509.574 $ | -385.722 $ | -13,3 % | 2.895.296 $ | +423.818 $ | +17,1 % | 2.471.478 $ | -290.482 $ | -10,5 % | 2.761.960 $ | +1.419.076 $ | +105,7 % |
| Rallybio Corp | RLYB | 2.617.338 $ | +126.298 $ | +5,1 % | 2.491.040 $ | +679.309 $ | +37,5 % | 1.811.731 $ | +584.546 $ | +47,6 % | 1.227.185 $ | -1.149.124 $ | -48,4 % |
| Adverum Biotechnologies, Inc. | ADVM | 2.453.747 $ | +1.289.165 $ | +110,7 % | 1.164.582 $ | -1.202.498 $ | -50,8 % | ||||||
| Mersana Therapeutics, Inc. | 405.072 $ | +18.792 $ | +4,9 % | 386.280 $ | -62.901 $ | -14,0 % | |||||||
| 360.208.609 $ | +76.924.711 $ | +23,3 % | 318.102.880 $ | +74.239.119 $ | +66,8 % | 273.045.105 $ | +46.155.360 $ | +44,7 % | 260.119.590 $ | +3.584.078 $ | +6,5 % | ||